These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37106259)

  • 1. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study.
    Luo Y; Cao Z; Ye H; Wu S; Sun X
    J Neurol; 2023 Aug; 270(8):3876-3884. PubMed ID: 37106259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
    Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
    J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet Treatment in Moyamoya Disease: A Systematic Review.
    Kijpaisalratana N; Ariyaprakai C; Sriamornrattanakul K; Wongsuriyanan S; Akharathammachote N; Susantitaphong P; Suwanwela NC
    Cerebrovasc Dis Extra; 2024; 14(1):76-85. PubMed ID: 38697036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Functional Outcomes and Prognostic Factors in Two Types of Adult Moyamoya Diseases.
    Zhang M; Tang J; Liu N; Xue Y; Ren X; Fu J
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104846. PubMed ID: 32439351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis.
    Liu T; Qin M; Xiong X; Li T; Feng L; Lai X; Gao Y
    Front Neurol; 2023; 14():1132339. PubMed ID: 37409015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural clinical course of hemodynamically stable adult moyamoya disease.
    Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
    J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for adult patients with hemorrhagic moyamoya disease in the acute stage.
    Yu Z; Zheng J; Liu X; Wen D; Guo R; Li M; You C; Li H; Ma L; Yang M
    Clin Neurol Neurosurg; 2019 Sep; 184():105409. PubMed ID: 31302379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis.
    Wouters A; Smets I; Van den Noortgate W; Steinberg GK; Lemmens R
    Acta Neurol Belg; 2019 Sep; 119(3):305-313. PubMed ID: 31215004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuro-endoscopic management of hemorrhagic moyamoya disease in the acute stage: single institute experience.
    Mino M; Fujimura M; Endo H; Endo T; Sato K; Tominaga T
    Neurol Res; 2019 Dec; 41(12):1097-1103. PubMed ID: 31608819
    [No Abstract]   [Full Text] [Related]  

  • 13. Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis.
    Camps-Renom P; Alejaldre-Monforte A; Delgado-Mederos R; Martínez-Domeño A; Prats-Sánchez L; Pascual-Goñi E; Martí-Fàbregas J
    Eur J Neurol; 2017 Feb; 24(2):302-308. PubMed ID: 27801531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia and Clinical Outcomes in Intracerebral Hemorrhage: A Retrospective Multicenter Cohort Study.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Stroke; 2021 Jan; 52(2):611-619. PubMed ID: 33430632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on acute management of intracerebral haematoma using local thrombolysis in moyamoya and non-moyamoya patients: a single institution experience.
    Xu F; Lian L; Liang Q; Deng G; Zhang J; Wang S; Wang F; Tang Z; Zhu S
    Br J Neurosurg; 2023 Oct; 37(5):1082-1087. PubMed ID: 35475398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
    Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
    Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports.
    Koh MY; Toh KZ; Ho JS; Yeo LL; Ho AF; Sia CH; Tan BY
    J Thromb Thrombolysis; 2022 Aug; 54(2):339-349. PubMed ID: 35699873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions.
    Abedi A; Sizdahkhani S; Choi W; Nguyen VN; Rennert RC; Russin JJ
    Neurosurg Focus; 2023 Oct; 55(4):E9. PubMed ID: 37778042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage.
    Creutzfeldt CJ; Weinstein JR; Longstreth WT; Becker KJ; McPharlin TO; Tirschwell DL
    J Stroke Cerebrovasc Dis; 2009; 18(3):221-8. PubMed ID: 19426894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Clinical Characteristic and Risk Factors for Short-Term Prognosis of Moyamoya Disease with Intraventricular Hemorrhage in Adults.
    Tong P; Shan T; An J; Liu S; Jing G; Bi J; Wang Z
    World Neurosurg; 2023 Mar; 171():e738-e744. PubMed ID: 36608789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.